Pregnancy has long been a black box, managed with generic timelines and reactive interventions. Mirvie is cracking that box open, using RNA sequencing to predict complications like preeclampsia before symptoms ever appear.

"Most pregnancy tests tell you if you're pregnant. Mirvie tells you if you're safe."

The TIME Best Inventions 2025 award for their Encompass™ Test isn't just a PR win; it's validation in a conservative medical industry. Backed by heavyweights like General Catalyst and Sequoia, Mirvie is positioning itself as the 'Liquid Biopsy' for pregnancy—a category-defining play that moves beyond simple diagnostics into longitudinal health monitoring.

• Category Creation: They aren't just another prenatal app; they are establishing a new biological standard of care.
• Strategic Traffic: Low volume, high intent—prioritizing quality leads over vanity metrics.
• Clinical Validation: TIME recognition signals mainstream acceptance of their complex RNA platform.